![]() |
![]() |
![]() |
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |review |
�Human
papillomavirus (HPV) probably is the cause of almost all cervical cancer
worldwide
HPV
DNA is present in 93% of cervical cancer and its precursor lesions
�A
recent study estimates worldwide HPV prevalence in cervical carcinomas
at 99.7 percent (Walboomers et al., 1999).
�Studies
also suggest that persistence of HPV infection is related to the
development of cancer (Wallin, et al. 1999; Burk, 1999).
�Besides
HPV, other risk factors appear to include certain sexual activity
patterns and smoking (Brinton, 1992; Biswas et al., 1997; Prokopczyk et
al., 1997, Roteli-Martins et al., 1998; Wen et al., 1999).
�In
some developing countries, there is concern among clinicians that
cervical cancer develops differently from what is traditionally
described in Western countries (for example, concern that cervical
cancer may develop at younger ages and that dysplasia progresses more
quickly to invasive disease) (Rogo et al., 1990).
�A
study of Pap smear results from ob/gyn clinics in South Africa found
that a significant proportion of cervical cancer cases occurred in women
younger than age 40 (Lancaster et al., 1999). Whether these results
would have been the same with a true population-based sample is unclear.
Few studies have conclusively demonstrated regional differences in the
age-specific risk of cervical cancer; in general, cervical cancer risk
peaks around age 50, and severe dysplasia risk peaks around age 35
(Ponten et al., 1995).
|